| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |